Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge
Keywords: ADCC, Antibody dependent cellular cytotoxicity; CEF, chick embryo fibroblasts; cGMP, current good manufacturing processes; CRF, circulating recombinant form; CTL, cytotoxic T lymphocytes; DR, double recombinant; IFN-γ, interferon gamma; IP, immunoprecipit